Saliva: We are validated to use the OraGene Saliva Collection Kits For Diagnostics.
The TheraScreen kit (DxS Ltd, Manchester, UK) is a well-established CE-IVD-marked kit for diagnostic analysis of KRAS mutational status [ 24].
Immunoassays utilizing commercial kits designed for diagnostic use can be adapted and validated to meet Good Laboratory Practice (GLP) requirements to support pharmacokinetic (PK) studies.
The Beyond Zero campaign plans to raise Kenya Shillings 500 million for maternal, new-born and child health through the provision of mobile clinics, incubators, point of care diagnostic kits for early infant diagnostics of HIV and oxygen concentrators.
USAID is also sending 2,000 personal-protective-equipment kits, laboratory materials for diagnostic testing and other technical support.
CA 15 3 levels were determined by a direct chemiluminescent technology in the automated immunoanalyser system ADVIA Centaur® using a kit for human diagnostic oncology (Bayer Immuno 1 CA 15-3™ accordingcording to the manufacturer's protocol.
Another project is the open diagnostics initiative, which provides African doctors with DIY kits for a paper diagnostic device that can detect Ebola in 10 minutes, so the physicians can prepare for outbreaks.
The challenging organisational structure of the PMTCT programme further complicated the process of including priorities found meaningful at the local level: "The programme coordinator, for example, does not include PMTCT activities such as budgeting for diagnostic kits, medicines, delivery kits and delivery bed in the plan.
Companies are offering to users the possibility of buying ready to use kits for pyrosequencing especially diagnostic relevant biomarkers such as KRAS, MGMT, p16, LINE1, MLH1, and BRAF (Qiagen, Germany; EpigenDX, USA).
This is normally expected from commercially available kits for in vitro diagnostic use, but it is perhaps enhanced here by the fact that the cobas kit is linked to specific instrument and analysis software providing automated genotyping calls and, therefore, reducing the subjectivity of the interpretation.
"As the market for diagnostic kits continues to expand, and as new sequencers come to market, there will continue to be a plethora of different ways that clinicians can use genomic data to make a diagnosis.
